skip to main content
Idioma:
Primo Search
Clear Search Box
Search in: Busca Geral
Busca Avançada
Busca por Índices

Cancer patients affected by COVID-19: Experience from Milan, Lombardy

Bogani, Giorgio ; Ditto, Antonino ; Bosio, Sara ; Brusadelli, Claudia ; Raspagliesi, Francesco

Gynecologic oncology, 2020-08, Vol.158 (2), p.262-265 [Periódico revisado por pares]

United States: Elsevier Inc

Texto completo disponível

Citações Citado por
  • Título:
    Cancer patients affected by COVID-19: Experience from Milan, Lombardy
  • Autor: Bogani, Giorgio ; Ditto, Antonino ; Bosio, Sara ; Brusadelli, Claudia ; Raspagliesi, Francesco
  • Assuntos: Aged ; Aged, 80 and over ; Betacoronavirus - isolation & purification ; Cancer ; Coronavirus Infections - epidemiology ; Coronavirus Infections - pathology ; COVID-19 ; Female ; Genital Neoplasms, Female - epidemiology ; Genital Neoplasms, Female - therapy ; Genital Neoplasms, Female - virology ; Humans ; Italy - epidemiology ; Middle Aged ; Oncology ; Pandemics ; Pneumonia, Viral - epidemiology ; Pneumonia, Viral - pathology ; Retrospective Studies ; SARS-CoV-2
  • É parte de: Gynecologic oncology, 2020-08, Vol.158 (2), p.262-265
  • Notas: ObjectType-Article-1
    SourceType-Scholarly Journals-1
    ObjectType-Feature-2
    content type line 23
  • Descrição: SARS-CoV-2 pandemic is continuing to spread. There are growing concerns on the impact of COVID-19 in cancer patients. Several papers reporting recommendations and guidelines are published. But few data on cancer patients affected by COVID-19 are available. This is a retrospective study including all consecutive patients affected by gynecological cancer who developed COVID-19. All patients were treated in an academic setting (in Milan, Lombardy, Italy) between February and March 2020. Overall, 355 patients had active treatment during the study period due to newly diagnosed or recurrent gynecological disease. Among those, 19 (5.3%) patients affected developed COVID-19. All patients were asymptomatic at the time of COVID-19 detection. Six patients were diagnosed before starting planned treatments; while the remaining 13 were diagnosed for COVID-19 after their started their treatments. Considering the first group of six patients, one patient died due to COVID-19 3 days after the diagnosis; while the other patients recovered from COVID-19 after a median of three weeks. The latter group of 13 patients (treatments started) included five patients who underwent surgery and eight patients who underwent chemotherapy. Focusing on five patients who were diagnosed after surgery, we observed that two patients died during postoperative course, while in other two cases prolonged hospitalization was needed. One patient had no issues. Chemotherapy was delayed for the remaining patents without sequelae. Our report highlights that COVID-19 impacts the quality of treatments for cancer patients. Mortality rate is high, especially after surgery. More important, patients under active treatment for cancer are at high risk of developing severe evolution of COVID-19. Prioritizing patients journey during COVID-19 is of paramount importance. •There are growing concerns on the impact of COVID-19 in cancer patients.•COVID-19 is impacting oncologic practice directly and indirectly.•Prioritizing patients journey during COVID-19 is of paramount importance.
  • Editor: United States: Elsevier Inc
  • Idioma: Inglês
Links
Voltar para lista de resultados

  • Realização: ABCD-USP USP   Logos de Redes Sociais: Freepik

Buscando em bases de dados remotas. Favor aguardar.